A Phase 2 Study Comparing Chemotherapy in Combination With OGX-427 or Placebo in Patients With Bladder Cancer
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Daniel Petrylak, MD
Columbia University
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
55 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Tom Baker Cancer Center
Calgary, Alberta, Canada
- Cross Cancer Center
Edmonton, Alberta, Canada
- British Columbia Cancer Agency
Vancouver, British Columbia, Canada
- Juravinski Cancer Centre
Hamilton, Ontario, Canada
- R. S. Mclaughlin Durham Regional Cancer Center at Lakeridge Health
Oshawa, Ontario, Canada
- Princess Margaret Hospital
Toronto, Ontario, Canada
- Chum-Hospital Notre Dame
Montreal, Quebec, Canada
- Centre Hospitalier Régional Et Universitaire - Hôpital
Bretonneau Tours, Centre-Val de Loire, France
- Institute Jean Godinot
Reims, Champagne-Ardenne, France
- Centre Hospitalier Universitaire de Rouen
Rouen, Haute-Normandie, France
- Centre Paul Papin
Angers, Pays de la Loire Region, France
- Medicale Centre René Gauducheau
Saint-Herblain, Pays de la Loire Region, France
- Institut Paoli Calmettes
Marseille, Provence-Alpes-Côte d'Azur Region, France
- Centre Antoine Lacassagne
Nice, Provence-Alpes-Côte d'Azur Region, France
- Centre Hospitalier Universitaire, Institut Gustave Roussy
Villejuif, Île-de-France Region, France
- Universitätsklinikum Heidelberg
Heidelberg, Baden-Wurttemberg, Germany
- Klinikum Rechts Der Isar Der Technischen Universität
München, Bavaria, Germany
- Johann-Wolfgang-Goethe-Universität Frankfurt
Frankfurt am Main, Hesse, Germany
- Medizinische Hochschule Hannover
Hanover, Niedeersachen, Germany
- Universitätsklinikum Des Saarlandes
Homburg, Saarland, Germany
- Universitätsklinikum Dresden
Dresden, Saxony, Germany
- Universitätsklinikum Magdeburg A.Ö.R.
Magdeburg, Saxony-Anhalt, Germany
- Universitätsklinikum Jena
Jena, Thuringia, Germany
- Universitätsklinikum Mainz
Mainz, Germany
- Azienda Ospedaliero-Universitaria Policlinico Di Modena
Modena, Italy
- Fondazione Irccs Policlinico San Matteo Pavia
Pavia, Italy
- Unità Operativa Di Oncologia Medica
Roma, Italy
- Centrum Onkologii Im. Prof. Franciszka Lukaszczyka W Bydgoszczy
Bydgoszcz, Kuyavian-Pomeranian Voivodeship, Poland
- Akademicki Szpital Kliniczny Im. J. Mikulicza-Radeckiego We Wroclawiu
Wroclaw, Lower Silesian Voivodeship, Poland
- Nzoz Europejskie Centrum Zdrowia Otwock
Otwock, Masovian Voivodeship, Poland
- Centrum Onkologii Instytut Im. M. Sklodowskiej-Curie
Warsaw, Masovian Voivodeship, Poland
- Uniwersyteckie Centrum Kliniczne
Gdansk, Pomeranian Voivodeship, Poland
- Zaklad Opieki Zdrowotnej Mswia Z Warminsko-Mazurskim Centrum Onkologii W Olsztynie
Olsztyn, Warminski-Mazurskie, Poland
- Hospital Santa Creu I Sant Pau
Barcelona, Barcelona, Spain
- Hospital General Universitario Gregorio Marañon
Madrid, Madrid, Spain
- Hospital Universitario 12 de Octubre
Madrid, Madrid, Spain
- Hospital Clinic I Provincial de Barcelona
Barcelona, Spain
- Hospital Vall D´hebrón
Barcelona, Spain
- Hospital del Mar
Barcelona, Spain
- Institut Català D'Oncologia, Hospital Duran I Reynals
Madrid, Spain
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Oct 2011
- Primary completion
- 30 Nov 2014
- Completion
- 30 Nov 2014
- Last update posted
- 7 Oct 2016
- Registered enrollment
- 183
- Registry id
- NCT01454089
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.